Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TNF receptor-associated factor 6 (TRAF6) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the TRAF6 transcript that governs the post-transcriptional expression of the TRAF6 protein (UniProt Q9Y4K3). TRAF6 itself is a key E3 ubiquitin ligase and adapter protein that mediates signaling from the Toll-like receptor (TLR), interleukin-1 receptor (IL-1R), and tumor necrosis factor receptor (TNFR) superfamilies, playing a central role in innate and adaptive immunity (Taganov et al., 2006, PNAS). The 3'-UTR contains specific binding sites for various microRNAs, most notably miR-146a, which act as negative feedback regulators to prevent over-activation of inflammatory pathways. Dysregulation of this regulatory region or the microRNAs that target it is associated with chronic inflammatory diseases, such as rheumatoid arthritis, as well as various malignancies and myeloid disorders where TRAF6 is overexpressed (Starczynowski et al., 2010, Nature Medicine). Therapeutic strategies targeting the TRAF6 mRNA 3'-UTR involve the use of microRNA mimics or antisense oligonucleotides to downregulate TRAF6 expression and dampen pathological signaling. Consequently, this region serves as a focal point for developing precision medicines aimed at modulating immune responses and inhibiting tumor progression.
Regulatory molecules such as microRNAs or antisense oligonucleotides bind to specific sequences within the 3'-UTR to induce mRNA degradation or translational repression, thereby reducing the synthesis of the TRAF6 protein.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TNF receptor-associated factor 6 mRNA 3'-untranslated region (TRAF6 mRNA 3'-UTR).